Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Pergoquin
Active substances:
Estonian, English, Latin
ATC code: QN04BC02
Dosage form: tablet
Strength: 1mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated September 27, 2023)
Package information leaflet (PIL): EST  (last updated September 27, 2023)
Labelling:  (last updated September 27, 2023)
Indication: Symptomatic treatment of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID) (Equine Cushing’s Disease).
Safety features: No
Marketing authorization holder: Vetviva Richter GmbH 
Marketing authorization number: 2202 
Marketing authorization issued on: September 24, 2019 
Marketing authorization expires on: September 24, 2024 
Marketing authorization procedure type: Decentralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1782682  Pergoquin  tablet  1mg 50TK  Prescription           
1782693  Pergoquin  tablet  1mg 60TK  Prescription      27.03.2023     
1782705  Pergoquin  tablet  1mg 100TK  Prescription           
1782716  Pergoquin  tablet  1mg 150TK  Prescription           
1782727  Pergoquin  tablet  1mg 160TK  Prescription           
1782738  Pergoquin  tablet  1mg 200TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere